Buch, Englisch, Band 871, 230 Seiten, Paperback, Format (B × H): 155 mm x 235 mm, Gewicht: 4196 g
A Global Perspective
Buch, Englisch, Band 871, 230 Seiten, Paperback, Format (B × H): 155 mm x 235 mm, Gewicht: 4196 g
Reihe: American Society of Gene & Cell Therapy
ISBN: 978-3-319-35729-4
Verlag: Springer International Publishing
Regulatory Aspects of Gene Therapy and Cell Therapy Products: A Global Perspective is part of the American Society of Gene and Cell Therapy sub-series of the highly successful Advances in Experimental Medicine and Biology series. It is essential reading for graduate students, clinicians, and researchers interested in gene and cell therapy and the regulation of pharmaceuticals.
Zielgruppe
Research
Autoren/Hrsg.
Fachgebiete
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Gentherapie
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Pharmazie
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Vorklinische Medizin: Grundlagenfächer Humangenetik
Weitere Infos & Material
1. Regulatory Oversight of Gene Therapy and Cell Therapy Products in the US - FDA/CBER.- 2. US Oversight of Gene Therapy Products – NIH RAC.- 3. Regulatory Oversight of Gene Therapy and Cell Therapy Products in Canada - Health Canada.- 4. Overview of the Regulatory Oversight Implemented by the French Regulatory Authorities for the Clinical Investigation of Gene Therapy and Cell Therapy Products.- 5. Regulation of Clinical Trials with Advanced Therapy Medicinal Products (ATMP) in Germany.- 6. EU Clinical Trials Regulatory Oversight of Advanced Therapy Medicinal Products (ATMP): Perspectives from Various Member States.- 7. Regulatory Oversight of Gene Therapy and Cell Therapy Products in Switzerland - Swissmedic.- 8. Regulatory Oversight of Gene Therapy and Cell Therapy Products in Japan - Japan Ministry of Health, Labour and Welfare (MHLW) and Pharmaceutical and Medical Device Agency (PMDA).- 9. Regulatory Oversight of Gene Therapy and Cell Therapy Products in Korea - Korean Ministryof Food and Drug Safety (MFDS).- 10. Regulatory Oversight of Gene Therapy and Cell Therapy Products in Taiwan - Taiwan Food and Drug Administration (TFDA).- 11. Regulatory Oversight of Gene Therapy and Cell Therapy Products in Singapore - Singapore Health Science Authorities (HSA).- 12. Regulatory Oversight of Gene Therapy and Cell Therapy Products in Brazil - National Health Surveillance Agency (ANVISA).